Trends and impacts of SARS-CoV-2 genome sharing: a comparative analysis of China and the global community, 2020–2023
ObjectiveThe global sharing of pathogen genome sequences has been significantly expedited by the COVID-19 pandemic. This study aims to elucidate the global landscape of SARS-CoV-2 genome sharing between 2020 and 2023 with a focus on quantity, timeliness, and quality. Specifically, the characteristic...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-11-01
|
| Series: | Frontiers in Public Health |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fpubh.2024.1491623/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846162553086935040 |
|---|---|
| author | Yenan Feng Songqi Chen Anqi Wang Zhongfu Zhao Cao Chen |
| author_facet | Yenan Feng Songqi Chen Anqi Wang Zhongfu Zhao Cao Chen |
| author_sort | Yenan Feng |
| collection | DOAJ |
| description | ObjectiveThe global sharing of pathogen genome sequences has been significantly expedited by the COVID-19 pandemic. This study aims to elucidate the global landscape of SARS-CoV-2 genome sharing between 2020 and 2023 with a focus on quantity, timeliness, and quality. Specifically, the characteristics of China are examined.MethodsSARS-CoV-2 genomes along with associated metadata were sourced from GISAID database. The genomes were analyzed to evaluate the quantity, timeliness, and quality across different countries/regions. The metadata characteristics of shared genomes in China in 2023 were examined and compared with the actual demographic data of China in 2023.ResultsFrom 2020 to 2023, European countries consistently maintained high levels of genomic data sharing in terms of quantity, timeliness, and quality. In 2023, China made remarkable improvements in sequence sharing, ranking among the top 3.89% globally for quantity, 22.78% for timeliness, and 17.78% for quality. The genome sharing in China in 2023 covered all provinces with Shanghai Municipality contributing the most genomes. Human samples accounted for 99.73% of the shared genomes and exhibited three distinct peaks in collection dates. Males constituted 52.06%, while females constituted 47.94%. Notably, there was an increase in individuals aged 65 and above within the GISAID database compared to China’s overall population in 2023.ConclusionThe global sharing of SARS-CoV-2 genomes in 2020–2023 exhibited disparities in terms of quantity, timeliness, and quality. However, China has made significant advancements since 2023 by achieving comprehensive coverage across provinces, timely dissemination of data, and widespread population monitoring. Strengthening data sharing capabilities in countries like China during the SARS-CoV-2 pandemic will play a crucial role in containing and responding to future pandemics caused by emerging pathogens. |
| format | Article |
| id | doaj-art-71a48beb4cf04c10b2c549991f2b6f44 |
| institution | Kabale University |
| issn | 2296-2565 |
| language | English |
| publishDate | 2024-11-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Public Health |
| spelling | doaj-art-71a48beb4cf04c10b2c549991f2b6f442024-11-20T06:26:41ZengFrontiers Media S.A.Frontiers in Public Health2296-25652024-11-011210.3389/fpubh.2024.14916231491623Trends and impacts of SARS-CoV-2 genome sharing: a comparative analysis of China and the global community, 2020–2023Yenan FengSongqi ChenAnqi WangZhongfu ZhaoCao ChenObjectiveThe global sharing of pathogen genome sequences has been significantly expedited by the COVID-19 pandemic. This study aims to elucidate the global landscape of SARS-CoV-2 genome sharing between 2020 and 2023 with a focus on quantity, timeliness, and quality. Specifically, the characteristics of China are examined.MethodsSARS-CoV-2 genomes along with associated metadata were sourced from GISAID database. The genomes were analyzed to evaluate the quantity, timeliness, and quality across different countries/regions. The metadata characteristics of shared genomes in China in 2023 were examined and compared with the actual demographic data of China in 2023.ResultsFrom 2020 to 2023, European countries consistently maintained high levels of genomic data sharing in terms of quantity, timeliness, and quality. In 2023, China made remarkable improvements in sequence sharing, ranking among the top 3.89% globally for quantity, 22.78% for timeliness, and 17.78% for quality. The genome sharing in China in 2023 covered all provinces with Shanghai Municipality contributing the most genomes. Human samples accounted for 99.73% of the shared genomes and exhibited three distinct peaks in collection dates. Males constituted 52.06%, while females constituted 47.94%. Notably, there was an increase in individuals aged 65 and above within the GISAID database compared to China’s overall population in 2023.ConclusionThe global sharing of SARS-CoV-2 genomes in 2020–2023 exhibited disparities in terms of quantity, timeliness, and quality. However, China has made significant advancements since 2023 by achieving comprehensive coverage across provinces, timely dissemination of data, and widespread population monitoring. Strengthening data sharing capabilities in countries like China during the SARS-CoV-2 pandemic will play a crucial role in containing and responding to future pandemics caused by emerging pathogens.https://www.frontiersin.org/articles/10.3389/fpubh.2024.1491623/fullSARS-CoV-2genomic sequencedata sharingGISAIDChina |
| spellingShingle | Yenan Feng Songqi Chen Anqi Wang Zhongfu Zhao Cao Chen Trends and impacts of SARS-CoV-2 genome sharing: a comparative analysis of China and the global community, 2020–2023 Frontiers in Public Health SARS-CoV-2 genomic sequence data sharing GISAID China |
| title | Trends and impacts of SARS-CoV-2 genome sharing: a comparative analysis of China and the global community, 2020–2023 |
| title_full | Trends and impacts of SARS-CoV-2 genome sharing: a comparative analysis of China and the global community, 2020–2023 |
| title_fullStr | Trends and impacts of SARS-CoV-2 genome sharing: a comparative analysis of China and the global community, 2020–2023 |
| title_full_unstemmed | Trends and impacts of SARS-CoV-2 genome sharing: a comparative analysis of China and the global community, 2020–2023 |
| title_short | Trends and impacts of SARS-CoV-2 genome sharing: a comparative analysis of China and the global community, 2020–2023 |
| title_sort | trends and impacts of sars cov 2 genome sharing a comparative analysis of china and the global community 2020 2023 |
| topic | SARS-CoV-2 genomic sequence data sharing GISAID China |
| url | https://www.frontiersin.org/articles/10.3389/fpubh.2024.1491623/full |
| work_keys_str_mv | AT yenanfeng trendsandimpactsofsarscov2genomesharingacomparativeanalysisofchinaandtheglobalcommunity20202023 AT songqichen trendsandimpactsofsarscov2genomesharingacomparativeanalysisofchinaandtheglobalcommunity20202023 AT anqiwang trendsandimpactsofsarscov2genomesharingacomparativeanalysisofchinaandtheglobalcommunity20202023 AT zhongfuzhao trendsandimpactsofsarscov2genomesharingacomparativeanalysisofchinaandtheglobalcommunity20202023 AT caochen trendsandimpactsofsarscov2genomesharingacomparativeanalysisofchinaandtheglobalcommunity20202023 |